White label – Pompe disease - ClinicalTrials.eu

Study on Indapamide for Patients with Chronic Post-Surgical Hypoparathyroidism

Recruiting

3 1 1
Investigated Drugs:
- INDAPAMIDE HEMIHYDRATE
Study on Daridorexant’s Effect on Cognitive Performance in Patients with Chronic Insomnia Disorder

Recruiting

3 1 1 1
Investigated Diseases:
- Insomnia
Investigated Drugs:
- Daridorexant
Study on Oral Arsenic Trioxide for Patients with Low-Risk Myelodysplastic Syndromes Not Responding to Erythropoiesis Stimulating Agents and Luspatercept

Recruiting

1 1 1
Investigated Drugs:
- Arsenic Trioxide
Study Comparing Amivantamab and Drug Combination for Patients with Recurrent or Metastatic Colorectal Cancer Without KRAS/NRAS and BRAF Mutations

Recruiting

3 1 1 1
Investigated Diseases:
- Colorectal cancer
Investigated Drugs:
+4
Study on the Effect of Carvedilol for Patients with Cirrhotic Portal Hypertension

Recruiting

2 1 1 1
Investigated Diseases:
- Hepatic cirrhosis
Investigated Drugs:
- Carvedilol
A study of ruxolitinib as first treatment for children with haemophagocytic lymphohistiocytosis (HLH)

Recruiting

2 1 1 1
Investigated Diseases:
- Haemophagocytic lymphohistiocytosis
Investigated Drugs:
- Ruxolitinib
Study on the Safety and Effectiveness of ARI0002h and Drug Combination for Newly Diagnosed Primary Plasma Cell Leukemia Patients

Recruiting

2 1 1 1
Investigated Drugs:
Study on Preventing Atrial Fibrillation After Heart Surgery Using Landiolol Hydrochloride in Patients with Normal Heart Function

Recruiting

3 1 1
Investigated Diseases:
- Ejection fraction normal
- Sinus rhythm
Investigated Drugs:
- Landiolol Hydrochloride
Study on Stopping Dupilumab in Patients with Severe Asthma Who Have Been on the Drug for Over 3 Years

Recruiting

3 1 1 1
Investigated Diseases:
- Asthma
Investigated Drugs:
- Dupilumab
Study of SGT-003 Gene Therapy for Safety and Tolerability in Walking Males with Duchenne Muscular Dystrophy

Recruiting

2 1 1
Investigated Diseases:
- Duchenne muscular dystrophy
Investigated Drugs:
- SGT-003

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies